Moderna, Inc. (MRNA) earnings
MRNA earnings moved a median of -0.47% by the close. Quarterly and annual MRNA reports and results, each read against the price at its own news timestamp. Back to the MRNA overview →
31 measured MRNA earnings events.
Where these MRNA earnings landedvs 31 measured MRNA earnings reactions
| Middle 50% of MRNA earnings reactions | -3.69% to +1.98% |
|---|---|
| Median reaction (to close) | -0.47% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 MRNA earnings events with a measured close landed between -3.69% and +1.98%; 42% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026 | Press release | +1.19% | +4.15% | |
| Form 10-Q Moderna, Inc. For: Jun 30 | SEC filing · Form 10-Q | -3.42% | +0.71% | |
| Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates | Press release | +0.88% | -4.01% | |
| Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026 | Press release | +1.63% | +3.74% | |
| Form 10-Q Moderna, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.75% | +3.96% | |
| Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates | Press release | -2.86% | -2.70% | |
| Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026 | Press release | +1.06% | +0.57% | |
| Form 10-K Moderna, Inc. For: Dec 31 | SEC filing · Form 10-K | +4.72% | +2.97% | |
| Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026 | Press release | -3.84% | -2.60% | |
| Form 10-Q Moderna, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.17% | +2.81% | |
| Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates | Press release | -3.49% | -3.41% | |
| Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 | Press release | -1.22% | -2.86% | |
| Form 10-Q Moderna, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.02% | -1.18% | |
| Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates | Press release | -2.33% | -0.27% | |
| Form 10-Q Moderna, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.02% | -0.47% | |
| Moderna Reports First Quarter 2025 Financial Results and Provides Business Updates | Press release | -3.82% | -2.67% | |
| Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 | Press release | -1.94% | -5.11% | |
| Form 10-K Moderna, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.12% | +4.65% | |
| Form 10-Q Moderna, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.10% | -7.36% | |
| Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates | Press release | -4.78% | -11.24% | |
| Moderna to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024 | Press release | -0.66% | -3.96% | |
| Form 10-Q Moderna, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.28% | -5.04% | |
| Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates | Press release | -4.00% | -5.43% | |
| Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024 | Press release | +0.44% | +1.15% | |
| Form 10-Q Moderna, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.14% | +0.00% | |
| Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates | Press release | +2.48% | +9.34% | |
| Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024 | Press release | -0.67% | -1.62% | |
| CARsgen Announced 2023 Annual Results | Press release | -2.17% | +0.92% | |
| Form 10-K Moderna, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.51% | +0.94% | |
| Form 10-Q Moderna, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.44% | -7.58% | |
| Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates | Press release | +0.78% | +10.43% |
Keep exploring
More MRNA: analyst actions → · SEC filings → · MRNA overview →